Search for other papers by Maria Luisa Garo in
Google Scholar
PubMed
Search for other papers by Désirée Deandreis in
Google Scholar
PubMed
Search for other papers by Alfredo Campennì in
Google Scholar
PubMed
Search for other papers by Alexis Vrachimis in
Google Scholar
PubMed
Search for other papers by Petra Petranovic Ovcaricek in
Google Scholar
PubMed
Clinic for Nuclear Medicine, University Hospital of Zürich, Zürich, Switzerland
Search for other papers by Luca Giovanella in
Google Scholar
PubMed
Introduction Differentiated thyroid cancer (DTC) accounts for 90% of all thyroid cancers and is increasing threefold every decade ( 1 ) so that by 2040 it will be the fourth most common malignancy in the group aged 20–49 years ( 2 ). Papillary
Search for other papers by Simonetta Piana in
Google Scholar
PubMed
Search for other papers by Eleonora Zanetti in
Google Scholar
PubMed
Search for other papers by Alessandra Bisagni in
Google Scholar
PubMed
Search for other papers by Alessia Ciarrocchi in
Google Scholar
PubMed
Search for other papers by Davide Giordano in
Google Scholar
PubMed
Search for other papers by Federica Torricelli in
Google Scholar
PubMed
Search for other papers by Teresa Rossi in
Google Scholar
PubMed
Search for other papers by Moira Ragazzi in
Google Scholar
PubMed
) and six were hyalinizing trabecular tumors (HTT). The remaining were malignant lesions. 68.1% were classical well-differentiated thyroid cancers, papillary thyroid carcinoma (PTC, n = 48, 54.5%) and follicular thyroid carcinoma (FTC, n = 12, 13
Search for other papers by Abdul K Siraj in
Google Scholar
PubMed
Search for other papers by Rong Bu in
Google Scholar
PubMed
Search for other papers by Maham Arshad in
Google Scholar
PubMed
Search for other papers by Kaleem Iqbal in
Google Scholar
PubMed
Search for other papers by Sandeep Kumar Parvathareddy in
Google Scholar
PubMed
Search for other papers by Tariq Masoodi in
Google Scholar
PubMed
Search for other papers by Laila Omar Ghazwani in
Google Scholar
PubMed
Search for other papers by Saif S Al-Sobhi in
Google Scholar
PubMed
Search for other papers by Fouad Al-Dayel in
Google Scholar
PubMed
Search for other papers by Khawla S Al-Kuraya in
Google Scholar
PubMed
cancer, among females in Saudi Arabia, with a significantly higher incidence rate when compared to other countries, such as the USA ( 2 , 3 ). Amongst the different subtypes, papillary thyroid cancer (PTC) is the most common and accounts for 80–90% of
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Search for other papers by Marra Jai Aghajani in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
South West Sydney Clinical School, UNSW Sydney, Sydney, Australia
Search for other papers by Tara Laurine Roberts in
Google Scholar
PubMed
Saint Vincent’s Clinical School, UNSW Sydney, Sydney, Australia
SydPath, Saint Vincent’s Hospital, Sydney, Australia
Search for other papers by Tao Yang in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Search for other papers by Charles Eugenio McCafferty in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Centre for Oncology Education and Research Translation (CONCERT), Liverpool, New South Wales, Australia
Search for other papers by Nicole J Caixeiro in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
South West Sydney Clinical School, UNSW Sydney, Sydney, Australia
Search for other papers by Paul DeSouza in
Google Scholar
PubMed
School of Medicine, Western Sydney University, Campbelltown, New South Wales, Australia
Department of Head & Neck Surgery, Liverpool Hospital, Liverpool, New South Wales, Australia
Department of Clinical Medicine, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
Search for other papers by Navin Niles in
Google Scholar
PubMed
). Differentiated thyroid cancers (DTC; both papillary (PTC) and follicular (FTC) histologies), derived from thyroid follicular cells, are the most common subtype, accounting for approximately 90% of all newly diagnosed cases ( 2 ). Standard of care for these
Search for other papers by Weiwei Liang in
Google Scholar
PubMed
Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China
Search for other papers by Yilin Zhang in
Google Scholar
PubMed
Search for other papers by Yan Guo in
Google Scholar
PubMed
Search for other papers by Pengyuan Zhang in
Google Scholar
PubMed
Search for other papers by Jiewen Jin in
Google Scholar
PubMed
Search for other papers by Hongyu Guan in
Google Scholar
PubMed
Search for other papers by Yanbing Li in
Google Scholar
PubMed
Introduction Thyroid cancer is the most common cancer in the endocrine system around the globe, being classified into three main histological subtypes: differentiated (papillary and follicular thyroid cancer), undifferentiated (poorly
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Wensi Huang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Yuying Deng in
Google Scholar
PubMed
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
fourth most common malignant tumor among women ( 1 ). More than 95% of thyroid cancer cases involve differentiated thyroid cancer (DTC) and up to 90% belong to papillary thyroid cancer (PTC) ( 2 ). The BRAF V600E mutation is the most common genetic
Search for other papers by C Chiapponi in
Google Scholar
PubMed
Search for other papers by H Alakus in
Google Scholar
PubMed
Search for other papers by M Faust in
Google Scholar
PubMed
Search for other papers by A M Schultheis in
Google Scholar
PubMed
Search for other papers by J Rosenbrock in
Google Scholar
PubMed
Search for other papers by M Schmidt in
Google Scholar
PubMed
, alongside with complete tumor resection, low morbidity, and satisfying cosmetic results ( 1 ). The use of prophylactic resection of clinically not involved central lymph nodes for papillary thyroid cancer (PTC), for example, is very controversial ( 2 , 3
Search for other papers by Yuting Shao in
Google Scholar
PubMed
Search for other papers by Xiaole Hu in
Google Scholar
PubMed
Search for other papers by Yuxi Wang in
Google Scholar
PubMed
Search for other papers by Yi Shao in
Google Scholar
PubMed
Search for other papers by Luchuan Li in
Google Scholar
PubMed
Search for other papers by Qingdong Zeng in
Google Scholar
PubMed
Search for other papers by Hong Lai in
Google Scholar
PubMed
Search for other papers by Lei Sheng in
Google Scholar
PubMed
associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer . Thyroid 2014 24 1618 – 1624 . ( https://doi.org/10.1089/thy.2014.0090 ) 16 Demircioglu ZG Aygun N Demircioglu MK Ozguven BY & Uludag M
Grupo de Citogenética, Filogenia y Evolución de Poblaciones, Facultad de Ciencias y Facultad de Ciencias de la Salud, Universidad del Tolima, Ibagué, Tolima, Colombia
Facultad de Ciencias para la Salud, Universidad de Caldas, Manizales, Caldas, Colombia
Search for other papers by Ana P Estrada-Flórez in
Google Scholar
PubMed
Search for other papers by Mabel E Bohórquez in
Google Scholar
PubMed
Hospital Pablo Tobón Uribe, Medellín, Antioquia, Colombia
Search for other papers by Alejandro Vélez in
Google Scholar
PubMed
Search for other papers by Carlos S Duque in
Google Scholar
PubMed
Search for other papers by Jorge H Donado in
Google Scholar
PubMed
Search for other papers by Gilbert Mateus in
Google Scholar
PubMed
Search for other papers by Cesar Panqueba-Tarazona in
Google Scholar
PubMed
Search for other papers by Guadalupe Polanco-Echeverry in
Google Scholar
PubMed
Search for other papers by Ruta Sahasrabudhe in
Google Scholar
PubMed
Search for other papers by Magdalena Echeverry in
Google Scholar
PubMed
Dinamica IPS, Medellín, Antioquia, Colombia
University of California Davis Comprehensive Cancer Center, Sacramento, California, USA
Fundación de Genética y Genómica, Medellín, Antioquia, Colombia
Search for other papers by Luis G Carvajal-Carmona in
Google Scholar
PubMed
Introduction In the United States and several other countries, the incidence of papillary thyroid cancer (PTC) has significantly increased in recent decades ( 1 ). PTC is now the second most commonly diagnosed malignancy among US Latinas ( 2
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Marco Marino in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Valentina Cirello in
Google Scholar
PubMed
Search for other papers by Valentina Gnarini in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Elisa Pignatti in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Livio Casarini in
Google Scholar
PubMed
Search for other papers by Chiara Diazzi in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Vincenzo Rochira in
Google Scholar
PubMed
Search for other papers by Katia Cioni in
Google Scholar
PubMed
Search for other papers by Bruno Madeo in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Cesare Carani in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Manuela Simoni in
Google Scholar
PubMed
Unit and Chair of Endocrinology and Metabolism, Center for Genomic Research, Department of Clinical Sciences and Community Health, Endocrine Unit, Azienda USL of Modena, NOCSAE, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Pietro Giardini 1355, 41126 Modena, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Introduction Thyroid cancers can be well-differentiated, as papillary and follicular subtypes, or poorly differentiated and anaplastic carcinomas. Papillary thyroid carcinoma (PTC) represents up to 80% of all the thyroid cancer cases. Various